Through in-depth studies of the Linc00205/miR-154–3p/ROCK1/MAPK axis, we hope to identify new targeted therapeutic strategies to intervene in the progression and metastasis of HB. The gene discussed is LINC00205; the disease is hemoglobin measurement.